All About

HEOR | RWE

At KMK, our over 20 years of expertise enable us to develop your product's value story to reveal business insights for more educated decision-making including the use of real-world studies to showcase your drug’s efficacy and its value in the marketplace.

Get a detailed vision of our HEOR, Real World Data & Real-World Evidence solutions and offerings.

KMK’s Latest Case Studies

Case Studies

Discover

IN-DEPTH
ANALYSIS

Explore KMK’s customer success stories and discover how our expert team helps clients identify their problems, come up with the best solution, and deliver results.

KMK’s Latest

White Papers

Our

LATEST
RESEARCH

KMK’s best thinking & expertise will guide you to better understand complex business problems and determine the best way forward for your business.

Migraine Study Demonstrates Impact of Treatment Failures on Healthcare System

Heor

Exploring the significance of Real World Evidence and Real World Data

Heor

Smarter Real World Evidence: A Flexible Client-Centered Dashboard Can Help Data Tell a Better Story

Heor

KMK’s Latest

Webinar

Learn From

EXPERTS

Watch KMK’s expert opinions and discussions on the latest industry trends to gain deeper insight and learn the best way to plan feasible commercial strategies for your business.

Looking Ahead in Oncology

Heor Oncology

KMK’s Latest

Publications

Gain

INSIGHTFUL
KNOWLEDGE

Read the latest publications by KMK leaders and experts and learn more about the dynamics of the pharmaceutical industry to identify new opportunities and maintain a competitive edge.

Economic Burden Associated With Extrapyramidal Symptoms In A Medicaid Population With Schizophrenia

Resource Utilization, Costs And Treatment Patterns Of Switching And Discontinuing Treatment Of MS Patients With High Relapse Activity

Difference-In-Differences Method In Comparative Effectiveness Research: Utility With Unbalanced Groups

Real-World Adherence And Persistence To Oral Disease-Modifying Therapies In Multiple Sclerosis Patients Over 1 Year

Impact of switching to fingolimod versus injectable disease-modifying therapy cycling on risk of multiple sclerosis-related relapses: A retrospective analysis

Utilization and Treatment Patterns of Disease-Modifying Therapy Among Pediatric Patients With Multiple Sclerosis in the United States

Annual Cost Burden by Level of Relapse Severity in Patients with Multiple Sclerosis

Group-Based Trajectory Modeling To Assess Adherence To Biologics Among Patients With Psoriasis

Clinical Symptoms And Self-Reported Disease Severity Among Patients With Psoriasis – Implications For Psoriasis Management

Economic Impact Of Above-Label Dosing With Etanercept, Adalimumab, Or Ustekinumab In Patients With Psoriasis

Incidence Rates Of Comorbidities Among Patients With Psoriasis In The United States

Incidence and prevalence of psoriatic arthritis in patients with psoriasis stratified by psoriasis disease severity: Retrospective analysis of an electronic health records database in the United States

Assessing The Importance Of Predictors In Unplanned Hospital Readmissions For Chronic Obstructive Pulmonary Disease

Economic Burden Of Chronic Obstructive Pulmonary Disease By Presence Of Comorbidities

Effects Of Gold-Adherent Prescribing On COPD Symptom Burden, Exacerbations, And Health Care Utilization In A Real-World Setting

Evaluation Of Exacerbations And Blood Eosinophils In UK And US COPD Populations: Findings From A Cohort Analysis

Treatment Patterns And Costs For Anti-Tnfα Therapy In Patients With Ankylosing Spondylitis

Healthcare Resource Utilization And Direct Costs In Patients With Ankylosing Spondylitis And Psoriatic Arthritis In A Large US Cohort

Healthcare Utilization and Cost Associated With Switching Biologics Within the First Year of Biologic Treatment Initiation Among Patients With Ankylosing Spondylitis

Adherence To Tobramycin Inhaled Powder Vs Inhaled Solution In Patients With Cystic Fibrosis: Analysis Of US Insurance Claims Data

Economic Impact Of Biologic Utilization Patterns In Patients With Psoriatic Arthritis

Healthcare Cost and Utilization Associated With Biologic Treatment Patterns Among Patients With Psoriatic Arthritis: Analyses From a Large US Claims Database

Burden Of Illness And Healthcare Resource Use In Patients With Sporadic Inclusion Body Myositis: A Retrospective Claims Database Analysis In The United States

A Protective Association Of Selective Serotonin Reuptake Inhibitors And A Harmful Association Of Calcium Channel Blockers For Primary Open-Angle Glaucoma Identified In A Healthcare Database Analysis

Healthcare Costs And Resource Utilization In Patients With Severe Aplastic Anemia In The US

Healthcare Resource Use And Direct Costs In Severe Aplastic Anemia (SAA) Patients Before And After Treatment With Eltrombopag

High Healthcare Utilization In Adolescents With Sickle Cell Disease Prior To Transition To Adult Care: A Retrospective Study

Healthcare Resource Utilization, Treatment Patterns, And Cost Of Care Among Patients With Thermal Burns And Inpatient Autografting In Two Large Privately Insured Populations In The United States

Treatment patterns and health care costs in commercially insured patients with follicular lymphoma

Patient characteristics and drug utilization of heart failure patients prescribed Sodium-glucose cotransporter-2 inhibitors (SGLT2i) and sacubitril/valsartan, a real-world database cohort study of Optum® electronic health record data source

Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis

Real-world treatment patterns and outcomes from an electronic medical records database for patients with rheumatoid arthritis treated with repository corticotropin injection

Post Hoc Analysis of the Correlation Between Patient Reported Outcomes and Clinical Response to Repository Corticotropin Injection for Persistently Active Rheumatoid Arthritis

Healthcare Utilization and Costs in Patients with Migraine Who Have Failed Previous Preventive Treatments

Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study

Effectiveness of erenumab and onabotulinumtoxinA on acute medication usage and health care resource utilization as migraine prevention in the United States

Comparative effectiveness of erenumab versus oral preventive medications among migraine patients: A US claims database study

Economic Burden Associated With Extrapyramidal Symptoms In A Medicaid Population With Schizophrenia

Resource Utilization, Costs And Treatment Patterns Of Switching And Discontinuing Treatment Of MS Patients With High Relapse Activity

Difference-In-Differences Method In Comparative Effectiveness Research: Utility With Unbalanced Groups

Real-World Adherence And Persistence To Oral Disease-Modifying Therapies In Multiple Sclerosis Patients Over 1 Year

Impact of switching to fingolimod versus injectable disease-modifying therapy cycling on risk of multiple sclerosis-related relapses: A retrospective analysis

Utilization and Treatment Patterns of Disease-Modifying Therapy Among Pediatric Patients With Multiple Sclerosis in the United States

Annual Cost Burden by Level of Relapse Severity in Patients with Multiple Sclerosis

Group-Based Trajectory Modeling To Assess Adherence To Biologics Among Patients With Psoriasis

Clinical Symptoms And Self-Reported Disease Severity Among Patients With Psoriasis – Implications For Psoriasis Management

Economic Impact Of Above-Label Dosing With Etanercept, Adalimumab, Or Ustekinumab In Patients With Psoriasis

Incidence Rates Of Comorbidities Among Patients With Psoriasis In The United States

Incidence and prevalence of psoriatic arthritis in patients with psoriasis stratified by psoriasis disease severity: Retrospective analysis of an electronic health records database in the United States

Assessing The Importance Of Predictors In Unplanned Hospital Readmissions For Chronic Obstructive Pulmonary Disease

Economic Burden Of Chronic Obstructive Pulmonary Disease By Presence Of Comorbidities

Effects Of Gold-Adherent Prescribing On COPD Symptom Burden, Exacerbations, And Health Care Utilization In A Real-World Setting

Evaluation Of Exacerbations And Blood Eosinophils In UK And US COPD Populations: Findings From A Cohort Analysis

Treatment Patterns And Costs For Anti-Tnfα Therapy In Patients With Ankylosing Spondylitis

Healthcare Resource Utilization And Direct Costs In Patients With Ankylosing Spondylitis And Psoriatic Arthritis In A Large US Cohort

Healthcare Utilization and Cost Associated With Switching Biologics Within the First Year of Biologic Treatment Initiation Among Patients With Ankylosing Spondylitis

Adherence To Tobramycin Inhaled Powder Vs Inhaled Solution In Patients With Cystic Fibrosis: Analysis Of US Insurance Claims Data

Economic Impact Of Biologic Utilization Patterns In Patients With Psoriatic Arthritis

Healthcare Cost and Utilization Associated With Biologic Treatment Patterns Among Patients With Psoriatic Arthritis: Analyses From a Large US Claims Database

Burden Of Illness And Healthcare Resource Use In Patients With Sporadic Inclusion Body Myositis: A Retrospective Claims Database Analysis In The United States

A Protective Association Of Selective Serotonin Reuptake Inhibitors And A Harmful Association Of Calcium Channel Blockers For Primary Open-Angle Glaucoma Identified In A Healthcare Database Analysis

Healthcare Costs And Resource Utilization In Patients With Severe Aplastic Anemia In The US

Healthcare Resource Use And Direct Costs In Severe Aplastic Anemia (SAA) Patients Before And After Treatment With Eltrombopag

High Healthcare Utilization In Adolescents With Sickle Cell Disease Prior To Transition To Adult Care: A Retrospective Study

Healthcare Resource Utilization, Treatment Patterns, And Cost Of Care Among Patients With Thermal Burns And Inpatient Autografting In Two Large Privately Insured Populations In The United States

Treatment patterns and health care costs in commercially insured patients with follicular lymphoma

Patient characteristics and drug utilization of heart failure patients prescribed Sodium-glucose cotransporter-2 inhibitors (SGLT2i) and sacubitril/valsartan, a real-world database cohort study of Optum® electronic health record data source

Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis

Real-world treatment patterns and outcomes from an electronic medical records database for patients with rheumatoid arthritis treated with repository corticotropin injection

Post Hoc Analysis of the Correlation Between Patient Reported Outcomes and Clinical Response to Repository Corticotropin Injection for Persistently Active Rheumatoid Arthritis

Healthcare Utilization and Costs in Patients with Migraine Who Have Failed Previous Preventive Treatments

Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study

Effectiveness of erenumab and onabotulinumtoxinA on acute medication usage and health care resource utilization as migraine prevention in the United States

Comparative effectiveness of erenumab versus oral preventive medications among migraine patients: A US claims database study

Migraine

Neurology: Clinical Practice

Unmet Need in the Market Economic Burden Increased with Number of Treatment Failures in Migraine Patients – A Retrospective Claims Database Analysis in the United States

KMK Participants : Lujia Zhou

Learn More

Psoriatic arthritis

Springer-Drugs-Real World Outcomes

Association Between Treatment Patterns and Healthcare Utilization Healthcare Cost and Utilization Associated With Biologic Treatment Patterns Among Patients With Psoriatic Arthritis: Analyses From a Large US Claims Database

KMK Participants : Piao OW, Zheng JZ

Learn More

Rheumatoid Arthritis

Rheumatology and Therapy

Understanding Real-world Patient Profiles & Identifying Primary Product Benefactor Patient Characteristics and Indicators of Treatment Initiation with Repository Corticotropin Injection in Patients with Rheumatoid Arthritis: A Claims Database Analysis

KMK Participant : Fahim M

Learn More

lymphoma

Real-World Treatment Patterns

Real-World Treatment Patterns among Patients with Mycosis Fungoides and Sézary Syndrome in the United States between 2018 and 2020

KMK Participant : Huanxue Z.

Learn More

Multiple Sclerosis

International Journal of MS Care

Impact of switching to fingolimod versus injectable disease-modifying therapy cycling on risk of multiple sclerosis-related relapses: A retrospective analysis

KMK Participants : Huanxue Zhou, Olivia Wenxian Piao

Learn More

Ankylosing spondylitis

Journal of Managed Care Specialty Pharmacy

Healthcare Utilization and Cost Associated With Switching Biologics Within the First Year of Biologic Treatment Initiation Among Patients With Ankylosing Spondylitis

KMK Participants : Piao OW, Zheng JZ

Learn More

Multiple Sclerosis

Advances in Therapy

Annual Cost Burden by Level of Relapse Severity in Patients with Multiple Sclerosis

KMK Participants : Huanxue Zhou

Learn More

Psoriasis

Clinicoeconomics And Outcomes Research

Group-Based Trajectory Modeling To Assess Adherence To Biologics Among Patients With Psoriasis

KMK Participants : Huanxue Zhou

Learn More

Migraine

The Journal of Headache and Pain

Real-world Product Value Demonstration Impact of erenumab on acute medication usage and health care resource utilization among migraine patients: a US claims database study

KMK Participants :Shen Y, Zhou L

Learn More

Multiple Sclerosis

International Journal of MS Care

Utilization and Treatment Patterns of Disease-Modifying Therapy Among Pediatric Patients With Multiple Sclerosis in the United States

KMK Participants : Mengru Wang

Learn More

Follicular Lymphoma

JHEOR

Treatment patterns and health care costs in commercially insured patients with follicular lymphoma

KMK Participants : Chen G

Learn More

Psoriasis

Journal Of Managed Care & Specialty Pharmacy

Economic Impact Of Above-Label Dosing With Etanercept, Adalimumab, Or Ustekinumab In Patients With Psoriasis

KMK Participants : Huanxue Zhou

Learn More

Solutions

Data Management

Sales Force Effectiveness

Advanced Analytics

Market Research

HEOR | RWE

Products

Business Intelligence Tool (BiT)

Incentive Compensation Plan (ICP)

Call Plan Management (CPM)

Account Planning Tool (SAL)

InTask App

Insights

Sales Force Effectiveness

HEOR | RWE

Market Research

About

Why KMK?

Careers

Newsroom

Leadership

Life @ KMK US

Life @ KMK India

Blogs

Solutions

Data Management

Sales Force Effectiveness

Advanced Analytics

Market Research

HEOR | RWE

Products

Business Intelligence Tool (BiT)

Incentive Compensation Plan (ICP)

Call Plan Management (CPM)

Account Planning Tool (SAL)

InTask App

Insights

Sales Force Effectiveness

HEOR | RWE

Market Research

About

Why KMK?

Careers

Newsroom

Leadership

Life @ KMK US

Life @ KMK India

All About

HEOR | RWE

At KMK, our over 20 years of expertise enable us to develop your product's value story to reveal business insights for more educated decision-making including the use of real-world studies to showcase your drug’s efficacy and its value in the marketplace.

Case Studies

White Paper

Webinars

Publications

Case Studies

Discover

IN-DEPTH ANALYSIS​

Explore KMK’s customer success stories and discover how our expert team helps clients identify their problems, come up with the best solution, and deliver results. ​

White Papers

Our

LATEST RESEARCH

KMK’s best thinking & expertise will guide you to better understand complex business problems and determine the best way forward for your business.

Learn From

EXPERTS

Watch KMK’s expert opinions and discussions on the latest industry trends to gain deeper insight and learn the best way to plan feasible commercial strategies for your business.

Gain

INSIGHTFULKNOWLEDGE

Read the latest publications by KMK leaders and experts and learn more about the dynamics of the pharmaceutical industry to identify new opportunities and maintain a competitive edge.

Economic Burden Associated With Extrapyramidal Symptoms In A Medicaid Population With Schizophrenia

Resource Utilization, Costs And Treatment Patterns Of Switching And Discontinuing Treatment Of MS Patients With High Relapse Activity

Difference-In-Differences Method In Comparative Effectiveness Research: Utility With Unbalanced Groups

Real-World Adherence And Persistence To Oral Disease-Modifying Therapies In Multiple Sclerosis Patients Over 1 Year

Impact of switching to fingolimod versus injectable disease-modifying therapy cycling on risk of multiple sclerosis-related relapses: A retrospective analysis

Utilization and Treatment Patterns of Disease-Modifying Therapy Among Pediatric Patients With Multiple Sclerosis in the United States

Annual Cost Burden by Level of Relapse Severity in Patients with Multiple Sclerosis

Group-Based Trajectory Modeling To Assess Adherence To Biologics Among Patients With Psoriasis

Clinical Symptoms And Self-Reported Disease Severity Among Patients With Psoriasis – Implications For Psoriasis Management

Economic Impact Of Above-Label Dosing With Etanercept, Adalimumab, Or Ustekinumab In Patients With Psoriasis

Incidence Rates Of Comorbidities Among Patients With Psoriasis In The United States

Incidence and prevalence of psoriatic arthritis in patients with psoriasis stratified by psoriasis disease severity: Retrospective analysis of an electronic health records database in the United States

IN-DEPTH
ANALYSIS

Explore KMK’s customer success stories and discover how our expert team helps clients identify their problems, come up with the best solution, and deliver results.

LATEST
RESEARCH

INSIGHTFUL
KNOWLEDGE